S100A8	gene symbol: S100A8. Functionality: calcium, zinc, protein binding; toll-like receptor binding; inflammatory response; leukocyte migration; autophagy; apoptosis; immune response; nf-kappab regulation; cytoskeleton organization; pathogen defense. Phenotype: inflammation; immune response; cell growth; skin cancer risk through chronic inflammation and immune modulation. 
KRT6A	gene symbol: KRT6A. Functionality: cytoskeleton structural constituent, protein binding, epithelial morphogenesis, cell proliferation, differentiation, cell killing, wound healing, defense response, antimicrobial response, intermediate filament organization, keratinization. Phenotype: skin cancer risk, keratin filament activity, epidermal structural integrity, altered cell proliferation and differentiation. 
KRT14	gene symbol: KRT14. Functionality: structural constituent cytoskeleton, protein binding, keratin filament binding, involved epidermis development, radiation response, keratinocyte differentiation, hair cycle, intermediate filament assembly, stem cell differentiation, epithelial cell differentiation. Phenotype: skin cancer, epidermolysis bullosa simplex, photosensitivity, keratinization disorders. 
S100A9	gene symbol: S100A9. Functionality: calcium, zinc ion binding; antioxidant, microtubule, toll-like receptor 4, rage receptor binding; modulates inflammatory, immune response, cell growth, apoptosis, cytoskeleton organization, nf-kappab activity. Phenotype: involved in skin cancer pathogenesis through chronic inflammatory responses, altered cell signaling, increased cell migration, and immune modulation. 
KRT5	gene symbol: KRT5. Functionality: structural constituent of cytoskeleton, protein binding, scaffold protein binding, involved in epidermis development, response to mechanical stimulus, regulation of cell migration and protein localization, intermediate filament polymerization and organization, keratinization. Phenotype: associated with skin cancer, impacts skin structure, function, and resilience, involved in epidermal integrity and response to environmental stressors. 
KRT6B	gene symbol: KRT6B. Functionality: structural constituent of cytoskeleton, protein binding, ectoderm development, intermediate filament organization, keratinization. Phenotype: involved in skin epidermis formation, affects keratin filament activity, associated with skin cancer risk 
KRT16	gene symbol: KRT16. Functionality: cytoskeleton structure, protein binding, epithelium morphogenesis, inflammation, cytoskeleton organization, keratinocyte differentiation, cell migration regulation, keratinization, hair cycle, immune response, skin barrier establishment. Phenotype: skin barrier defects, keratinocyte migration, epithelial differentiation, skin cancer, inflammation. 
KRT6C	gene symbol: KRT6C. Functionality: protein binding, intermediate filament cytoskeleton organization, structural constituent of skin epidermis. Phenotype: involvement in skin structure and keratinization, potential link to skin cancer 
KRT17	gene symbol: KRT17. Functionality: structural molecule activity, protein binding, regulation of cell growth, hair follicle morphogenesis, keratinization, translation regulation, intermediate filament organization, epithelial cell differentiation. Phenotype: associated with skin cancer, affects hair follicle development, involved in epithelial cell behavior and keratinization processes. 
MT-CO3	gene symbol: MT-CO3. Functionality: mitochondrial electron transport, cytochrome c to oxygen, complex iv assembly, cellular respiration, proton transport. Phenotype: altered mitochondrial function, potential impact on skin cancer risk. 
S100A7	gene symbol: S100A7. Functionality: calcium, zinc ion binding; protein, rage receptor binding; zinc ion sequestering; response to reactive oxygen species; angiogenesis; epidermis development; t cell, granulocyte, monocyte chemotaxis regulation; keratinocyte differentiation; lipopolysaccharide response; antimicrobial response; erk1, erk2 cascade regulation. Phenotype: increased skin cancer risk; altered immune response; epidermal abnormalities; enhanced angiogenesis; modified chemotaxis. 
MT-CO2	gene symbol: MT-CO2. Functionality: cytochrome-c oxidase activity, copper ion binding, protein binding, mitochondrial electron transport, proton transmembrane transport, atp synthesis. Phenotype: associated with skin cancer through mitochondrial dysfunction, affects cellular respiration and response to hypoxia. 
SFN	gene symbol: SFN. Functionality: protein binding, kinase inhibitor, cadherin binding, phosphoserine binding, protein sequestering, regulates transcription, cytochrome c release, keratinocyte development, protein export, apoptosis, cell division, adhesion, growth, keratinization, localization, immune response, cell cycle, skin barrier, stem cell proliferation, signal transduction. Phenotype: affects skin cancer progression, keratinocyte differentiation, epidermal cell differentiation, immune response regulation, cell proliferation, and adhesion. 
S100A2	gene symbol: S100A2. Functionality: calcium ion binding, protein binding, metal ion binding, endothelial cell migration. Phenotype: associated with skin cancer. 
MT-CO1	gene symbol: MT-CO1. Functionality: cytochrome-c oxidase activity, protein binding, heme binding, metal ion binding, mitochondrial electron transport, response to hypoxia, oxidative stress, copper ion, electrical stimulus, proton transmembrane transport, cellular respiration. Phenotype: altered mitochondrial function, potential role in skin cancer progression through disrupted electron transport and oxidative stress response 
ACTB	gene symbol: ACTB. Functionality: cytoskeletal structure, nucleosomal dna binding, chromatin remodeling, cell cycle regulation, protein binding, atp binding and hydrolysis, cell motility, transcription regulation, synaptic vesicle endocytosis, cell polarity, double-strand break repair. Phenotype: cell proliferation, differentiation, apoptosis regulation, platelet aggregation, skin cancer susceptibility, stem cell maintenance, axonogenesis, blood-brain barrier maintenance. 
PERP	gene symbol: PERP. Functionality: protein binding, tissue homeostasis, desmosome organization, notch signaling, cell-cell adhesion, proteolysis regulation, t cell apoptosis regulation, p53-mediated apoptosis, neutrophil chemotaxis, amelogenesis, endopeptidase activation. Phenotype: altered cell adhesion, disrupted tissue integrity, impaired apoptosis, potential skin cancer development 
SPRR1B	gene symbol: SPRR1B. Functionality: structural molecule activity, peptide cross-linking, keratinocyte differentiation, keratinization. Phenotype: epidermis development, cornified envelope formation, cytoplasmic localization, skin cancer association 
KRT10	gene symbol: KRT10. Functionality: protein binding, structural component of skin epidermis, heterodimerization, peptide cross-linking, keratinocyte differentiation, regulation of epidermis development, heterotetramerization, intermediate filament organization. Phenotype: associated with epidermis development, epithelial cell differentiation, skin structure integrity. 
KRT1	gene symbol: KRT1. Functionality: protein binding, carbohydrate binding, structural constituent of epidermis, signaling receptor activity, protein heterodimerization, complement activation, oxidative stress response, peptide cross-linking, fibrinolysis, angiogenesis regulation, inflammatory response regulation, protein heterotetramerization, skin barrier establishment. Phenotype: altered keratinization, compromised skin barrier, potential involvement in skin cancer progression. 
EEF1A1	gene symbol: EEF1A1. Functionality: trna binding, rna binding, translation elongation factor, gtpase activity, protein binding, calmodulin binding, gtp binding, kinase activator, kinase binding, molecular adaptor, translation elongation. Phenotype: skin cancer association, viral genome replication regulation, epidermal growth factor response, chaperone-mediated autophagy regulation 
RPLP1	gene symbol: RPLP1. Functionality: structural constituent of ribosome, protein binding, protein kinase activator activity, ribonucleoprotein complex binding. Phenotype: altered translational elongation and translation processes in cytoplasm, potentially affecting skin cell growth and proliferation. 
LGALS7B	gene symbol: LGALS7B. Functionality: encodes a member of the galectin family involved in cell-cell adhesion, cell-matrix interactions, and apoptosis regulation. Phenotype: associated with increased risk of skin cancer due to altered cell adhesion and apoptosis pathways. 
LGALS7	gene symbol: LGALS7. Functionality: protein binding, carbohydrate binding, apoptotic process, cell-cell adhesion. Phenotype: associated with skin cancer progression 
COL1A1	gene symbol: COL1A1. Functionality: enables protease, protein, and metal ion binding; structural constituent of extracellular matrix; involved in skeletal development, cell migration, collagen biosynthesis, and regulation of transcription. Phenotype: affects skin morphogenesis and bone formation; associated with skin cancer risk due to regulation of cell adhesion, migration, and extracellular matrix organization. 
FABP5	gene symbol: FABP5. Functionality: retinoic acid binding, fatty acid transmembrane transport, protein binding, lipid binding, glucose metabolism, lipid metabolism, prostaglandin regulation, sensory perception regulation. Phenotype: involved in skin cancer pathogenesis, affects epidermis development, impacts glucose homeostasis, modulates pain perception, influences thermogenesis, facilitates lipid transport. 
RPS12	gene symbol: RPS12. Functionality: rna binding, ribosome structure, wnt signaling regulation, protein binding, translation, ribosomal biogenesis, translational fidelity maintenance. Phenotype: potential involvement in skin cancer due to regulation of wnt signaling pathway and ribosomal function 
HLA-B	gene symbol: HLA-B. Functionality: tap binding, peptide antigen binding, adaptive immune response, antigen presentation, regulation of t cell activity, immune response modulation, chaperone binding. Phenotype: skin cancer susceptibility, immune response alteration, t cell mediated cytotoxicity, antigen presentation, protection from nk cell cytotoxicity 
MT-ND4	gene symbol: MT-ND4. Functionality: nadh dehydrogenase activity, mitochondrial electron transport, ubiquinone binding, proton transport, atp synthesis, complex i assembly. Phenotype: impacts skin cancer risk, mitochondrial dysfunction, hypoxia response, development processes, substance response 
RPLP2	gene symbol: RPLP2. Functionality: structural constituent of ribosome, protein binding, cytoplasmic translation, translational elongation. Phenotype: altered ribosomal function linked to disrupted protein synthesis in skin cancer 
ACTG1	gene symbol: ACTG1. Functionality: cytoskeleton constituent, protein binding, atp binding, hydrolase activity, profilin binding, ubiquitin ligase binding, focal adhesion, cell-cell junction, actin filament, axonogenesis, synaptic vesicle endocytosis, angiogenesis, gene expression regulation. Phenotype: implicated in skin cancer via cell migration regulation, wound healing, blood-brain barrier maintenance, stress fiber assembly, sarcomere organization, tight junction assembly, platelet aggregation, polarized epithelium morphogenesis. 
GJB2	gene symbol: GJB2. Functionality: gap junction channel activity, calcium ion binding, protein binding, identical protein binding, cell communication, gap junction assembly, transmembrane transport. Phenotype: skin cancer susceptibility, sensorineural hearing loss, skin disorders, cellular response to oxidative stress, developmental anomalies. 
B2M	gene symbol: B2M. Functionality: antigen presentation, protein binding, immune response regulation, t cell activation, iron homeostasis, neuron regulation. Phenotype: altered immune response, skin cancer susceptibility, iron metabolism imbalance, neurodevelopmental effects 
TPT1	gene symbol: TPT1. Functionality: rna binding, calcium ion binding, protein binding, regulates apoptotic process, calcium ion transport, intracellular calcium ion homeostasis, response to dna damage, virus response. Phenotype: increased skin cancer susceptibility, impaired apoptosis regulation, altered calcium homeostasis 
RPL13	gene symbol: RPL13. Functionality: rna binding, protein binding, ribosome structure, translation, blastocyst and bone development. Phenotype: altered ribosomal function, potential impact on cellular growth, possible link to skin cancer 
MT-ATP6	gene symbol: MT-ATP6. Functionality: proton transmembrane transport, atp synthesis, protein binding, mitochondrial function. Phenotype: mitochondrial dysfunction, potential skin cancer susceptibility 
RPS24	gene symbol: RPS24. Functionality: rna binding, ribosome structure, translation initiation, rrna processing, ribosomal biogenesis. Phenotype: skin cancer risk, erythrocyte homeostasis disruption, translational efficiency alteration 
PFN1	gene symbol: PFN1. Functionality: adenyl-nucleotide exchange factor activity, phosphotyrosine residue binding, rna binding, actin binding, phosphatidylinositol-4,5-bisphosphate binding, small gtpase binding, cadherin binding, proline-rich region binding. Phenotype: neural tube closure, epithelial cell migration regulation, actin cytoskeleton organization, chemical synaptic transmission modulation, synapse maturation, postsynaptic actin cytoskeleton modification, skin cancer risk 
KRTDAP	gene symbol: KRTDAP. Functionality: cell differentiation, epidermis development, active in extracellular space, located in lamellar body. Phenotype: associated with skin cancer, impact on keratinocyte proliferation and differentiation 
RPS6	gene symbol: RPS6. Functionality: rna binding, structural constituent of ribosome, protein binding, protein kinase binding, g1/s transition, translation, rrna processing, t cell proliferation, apoptosis regulation, ribosomal biogenesis, tor signaling, glucose homeostasis, erythrocyte development. Phenotype: skin cancer association via cell cycle regulation, immune response modulation, apoptosis balance, proliferation, cytoplasmic translation 
DMKN	gene symbol: DMKN. Functionality: protein binding, active in extracellular space, involved in cornified envelope assembly. Phenotype: associated with skin cancer, impacts skin barrier integrity 
RPLP0	gene symbol: RPLP0. Functionality: rna binding, ribosome structure, protein binding, translation, ribosome biogenesis, response to interleukin-4. Phenotype: potential involvement in skin cancer via altered protein synthesis and cellular response mechanisms 
MT-ND3	gene symbol: MT-ND3. Functionality: nadh dehydrogenase activity, electron transport, oxidative stress response, aerobic respiration, light intensity response, atp synthesis, glucocorticoid response, proton transport. Phenotype: mitochondrial dysfunction, skin cancer susceptibility, altered energy metabolism 
RPL37A	gene symbol: RPL37A. Functionality: rna binding, ribosome structure, protein binding, metal ion binding, translation, cytoplasmic translation. Phenotype: increased risk of skin cancer due to altered protein synthesis 
DSP	gene symbol: DSP. Functionality: epithelial cell-cell adhesion, rna binding, cytoskeleton structure, protein binding, scaffold protein binding, desmosome organization, epidermis development, keratinocyte differentiation, adherens junction organization, wound healing, skin development. Phenotype: skin cancer risk, epidermal integrity, cardiac conduction issues, heart rate regulation. 
CXCL14	gene symbol: CXCL14. Functionality: protein binding, chemokine activity, chemotaxis, signal transduction, cell-cell signaling, antimicrobial response. Phenotype: involved in skin cancer through immune response regulation, cell signaling, and chemotaxis. 
RPS18	gene symbol: RPS18. Functionality: rna binding, structural constituent of ribosome, protein binding, rrna binding, involved in cytoplasmic translation, active in postsynaptic density, nucleus, nucleoplasm, cytosol, ribosome, focal adhesion, membrane, extracellular exosome, cytoplasm, part of small ribosomal subunit, cytosolic ribosome, cytosolic small ribosomal subunit. Phenotype: potential link to skin cancer due to disruption in ribosomal function affecting protein synthesis 
RPS17	gene symbol: RPS17. Functionality: rna binding, ribosome structural constituent, cytoplasmic translation, rrna processing, translation, translational initiation, erythrocyte homeostasis, ribosomal small subunit biogenesis. Phenotype: alterations linked to disrupted protein synthesis and potential contribution to skin cancer development 
RPS8	gene symbol: RPS8. Functionality: rna binding, structural constituent of ribosome, protein binding, translation, ribosomal small subunit biogenesis. Phenotype: potentially linked to skin cancer through disrupted protein synthesis and ribosome function 
RPL13A	gene symbol: RPL13A. Functionality: rna binding, ribosome structure, translation, negative translation regulation, lipopolysaccharide response, homeostasis, macrophage chemotaxis, interferon response. Phenotype: affects skin cancer progression through ribosome-mediated translation control and immune response modulation 
MT-CYB	gene symbol: MT-CYB. Functionality: mitochondrial electron transport, ubiquinol-cytochrome-c reductase activity, protein complex binding, metal ion binding, response to hypoxia. Phenotype: skin cancer association linked to mitochondrial dysfunction, impaired electron transport, response to environmental stimuli. 
RPL11	gene symbol: RPL11. Functionality: rna binding, ribosome structural constituent, protein binding, 5s rrna binding, ubiquitin ligase inhibitor, ribosomal assembly, translation, gene expression regulation, signal transduction regulation, protein stabilization, nucleoplasm localization. Phenotype: skin cancer risk, altered protein synthesis, disrupted ribosome biogenesis, impaired p53 pathway, dysregulated cell cycle. 
RPL27A	gene symbol: RPL27A. Functionality: rna binding, ribosome structure, protein binding, translation. Phenotype: potential role in skin cancer due to involvement in protein synthesis and cellular translation processes 
RPL28	gene symbol: RPL28. Functionality: rna binding, structural constituent of ribosome, protein binding, cytoplasmic translation, translation. Phenotype: involved in skin cancer progression, affects protein synthesis in ribosomes 
MT-ND1	gene symbol: MT-ND1. Functionality: nadh dehydrogenase activity, electron transport, atp synthesis, protein binding. Phenotype: mitochondrial dysfunction, skin cancer susceptibility 
RPS27	gene symbol: RPS27. Functionality: dna binding, rna binding, ribosome structural component, protein binding, zinc ion binding, translation, rrna processing, ribosomal biogenesis. Phenotype: increased risk of skin cancer, altered ribosomal function, disrupted translation processes 
RPL32	gene symbol: RPL32. Functionality: rna binding, ribosomal structural component, translation, cytoplasmic translation. Phenotype: altered protein synthesis, potential impact on cellular growth, possible link to skin cancer 
CSTA	gene symbol: CSTA. Functionality: protease binding, cysteine-type endopeptidase inhibitor, protein binding, negative regulation of peptidase activity, peptide cross-linking, keratinocyte differentiation, cell-cell adhesion. Phenotype: skin cancer risk, impacts keratinocyte differentiation and adhesion, affects protease activity. 
RPL34	gene symbol: RPL34. Functionality: rna binding, structural constituent of ribosome, protein binding, cadherin binding, cytoplasmic translation. Phenotype: potential role in skin cancer due to involvement in translation regulation and ribosomal function 
RPL31	gene symbol: RPL31. Functionality: rna binding, ribosome structure, protein binding, translation. Phenotype: skin cancer susceptibility, altered translation, abnormal ribosome function 
COL1A2	gene symbol: COL1A2. Functionality: protease binding, extracellular matrix structure, protein binding, metal ion binding, smad binding, growth factor binding, signaling pathway involvement, collagen organization. Phenotype: skin morphogenesis, skeletal development, blood vessel development, bone mineralization, collagen metabolism, odontogenesis, blood pressure regulation. 
RPL8	gene symbol: RPL8. Functionality: rna binding, ribosomal structure, protein binding, rrna binding, translation. Phenotype: increased risk of skin cancer due to translation dysregulation 
SBSN	gene symbol: SBSN. Functionality: protein binding, located in extracellular exosome. Phenotype: associated with skin cancer, affects cell communication and signaling 
TMSB10	gene symbol: TMSB10. Functionality: protein binding, actin filament organization, actin monomer binding, cell migration regulation, actin monomer sequestering. Phenotype: altered cell migration, cytoskeletal disruptions, potential involvement in skin cancer progression 
ENO1	gene symbol: ENO1. Functionality: magnesium ion binding, rna polymerase ii transcription regulator, transcription corepressor, dna-binding transcription repressor, rna binding, phosphopyruvate hydratase activity, protein binding, homodimerization, cadherin binding, gtpase binding, gluconeogenesis, plasminogen activation, cell growth regulation, glycolysis. Phenotype: involved in negative regulation of transcription, hypoxia-induced apoptosis, atp biosynthesis, cell growth. located in cytoplasm, nucleus, extracellular space, plasma membrane, cell surface. associated with skin cancer risk, affecting cell proliferation and metabolism. 
RPS14	gene symbol: RPS14. Functionality: rna binding, ribosome structure, protein binding, translation regulation, mrna 5'-utr binding, ribosomal assembly, transcription regulation, translation, erythrocyte differentiation, ssu-rrna maturation, ribosome biogenesis. Phenotype: skin cancer association, affects cell growth, impacts ribosomal function, alters protein synthesis. 
RPL36	gene symbol: RPL36. Functionality: rna binding, ribosome structural constituent, protein binding, translation involvement, cytoplasmic translation. Phenotype: skin cancer association, altered protein synthesis, ribosomal function disruption 
SPRR2A	gene symbol: SPRR2A. Functionality: protein and lipid binding, antibacterial response, microbiota regulation, defense against gram-positive bacteria. Phenotype: skin barrier integrity, immune response regulation, potential influence on skin cancer development. 
RPL39	gene symbol: RPL39. Functionality: rna binding, ribosome structure, translation, immune response. Phenotype: skin cancer involvement, immune response modulation 
GSTP1	gene symbol: GSTP1. Functionality: glutathione transferase activity, glutathione peroxidase activity, fatty acid binding, protein binding, kinase regulation, nitric oxide binding, xenobiotic metabolism, oxidative stress response. Phenotype: negative regulation of inflammation, tumor necrosis factor, and apoptotic processes; cellular oxidant detoxification; skin cancer susceptibility. 
RPS27A	gene symbol: RPS27A. Functionality: rna binding, structural constituent of ribosome, protein binding, metal ion binding, ribosomal small subunit biogenesis, cytoplasmic translation, ubiquitin protein ligase binding, protein tag activity, protein ubiquitination. Phenotype: involvement in skin cancer through translation and protein modification, cellular localization in various membranes, cytoplasm, and extracellular spaces 
JUP	gene symbol: JUP. Functionality: transcription coactivator, structural molecule, protein binding, cell adhesion, desmosome assembly, wnt signaling. Phenotype: skin development, cell proliferation, cell migration, endothelial adhesion, regulation of heart rate, skin cancer risk. 
RPS19	gene symbol: RPS19. Functionality: rna binding, ribosome structure, protein binding, rrna processing, translation, immune response. Phenotype: linked to skin cancer, affects cell growth, immune response, ribosomal biogenesis 
RPL37	gene symbol: RPL37. Functionality: rna binding, structural component of ribosome, rrna binding, metal ion binding, mdm2/mdm4 binding, ubiquitin ligase inhibitor, translation regulation. Phenotype: altered p53 signal transduction, potential impact on cell cycle, implications in cancer progression 
RPL27	gene symbol: RPL27. Functionality: rna binding, ribosome structural constituent, protein binding, cytoplasmic translation, rrna processing, translation, aldosterone response. Phenotype: involved in cellular processes, potential impact on cell growth and division, implications in skin cancer development 
RPL3	gene symbol: RPL3. Functionality: rna binding, structural constituent of ribosome, protein binding, cytoplasmic translation, cellular response to interleukin-4. Phenotype: involvement in skin cancer, impacts ribosomal function, affects cellular response 
RPS29	gene symbol: RPS29. Functionality: ribosomal structural constituent, zinc ion binding, cytoplasmic translation. Phenotype: linked to skin cancer; abnormalities in ribosome biogenesis and function 
COL3A1	gene symbol: COL3A1. Functionality: protease binding, integrin binding, extracellular matrix structural constituent, smad binding, metal ion binding, growth factor binding, signaling pathways, wound healing, collagen fibril organization. Phenotype: skin development, response to radiation, tissue homeostasis, fibroblast proliferation, neuron migration, wound healing, skin cancer risk, extracellular matrix integrity. 
RPS11	gene symbol: RPS11. Functionality: rna binding, structural constituent of ribosome, protein binding, rrna binding, cytoplasmic translation, ribosomal small subunit biogenesis. Phenotype: skin cancer association, influence on ribosome function, potential impact on cellular protein synthesis 
CSTB	gene symbol: CSTB. Functionality: protease and rna binding, endopeptidase inhibitor, regulates proteolysis. Phenotype: impacts skin cancer risk, influences cell behavior and protein regulation. 
RPL9	gene symbol: RPL9. Functionality: rna binding, ribosome structure, protein binding, rrna binding, translation involvement. Phenotype: skin cancer association, potential alteration in protein synthesis, cell growth 
RACK1	gene symbol: RACK1. Functionality: rna binding, protein kinase c binding, signaling receptor binding, enzyme activator, ion channel inhibitor, translation regulator, molecular adaptor, apoptosis regulation, protein phosphorylation regulation. Phenotype: skin cancer link, cell migration regulation, pigmentation involvement, cell cycle control, apoptosis modulation, wnt signaling inhibition, growth factor response 
ANXA2	gene symbol: ANXA2. Functionality: calcium ion binding, protease binding, rna binding, serine-type endopeptidase inhibition, phospholipase a2 inhibition, vesicle budding, angiogenesis, receptor recycling regulation, fibrinolysis, collagen fibril organization, transcription regulation. Phenotype: skin cancer association, cell-matrix adhesion, epithelial cell apoptosis, plasma membrane repair, positive regulation of plasminogen activation, neurogenesis regulation, low-density lipoprotein metabolism. 
RPL7A	gene symbol: RPL7A. Functionality: rna binding, structural constituent of ribosome, protein binding, cadherin binding, involved in translation and maturation of lsu-rrna. Phenotype: potentially linked to skin cancer via disrupted protein synthesis and cellular adhesion affecting cell growth and apoptosis. 
RPL23	gene symbol: RPL23. Functionality: ribosome structural component, rna binding, protein binding, transcription coactivator binding, ubiquitin ligase inhibitor, regulates g1-g0 transition, translation, gene expression, protein stabilization, p53 signal transduction. Phenotype: involvement in skin cancer relates to cell proliferation regulation, transcriptional control, protein stability, signal transduction, potentially affecting tumor growth and suppression. 
RPL19	gene symbol: RPL19. Functionality: rna binding, ribosome structure, protein binding, translation involvement. Phenotype: altered protein synthesis, potential impact on cell growth and division related to skin cancer 
S100A11	gene symbol: S100A11. Functionality: protein binding, homodimerization, calcium-dependent binding, cadherin binding, signal transduction, regulation of dna replication and cell proliferation, smooth muscle cell migration, cell-cell adhesion. Phenotype: involved in skin cancer, affects cell proliferation, migration, adhesion, and signal transduction. 
RPS2	gene symbol: RPS2. Functionality: rna binding, mrna binding, ribosome structure, protein binding, fibroblast growth factor binding, enzyme binding, cadherin binding, translation, ubiquitin regulation. Phenotype: implicated in skin cancer, affects cell growth and division 
RPS28	gene symbol: RPS28. Functionality: rna binding, structural constituent of ribosome, protein binding, cytoplasmic translation, rrna processing, ribosome biogenesis, small subunit assembly and maturation. Phenotype: potential involvement in skin cancer through dysregulation of ribosomal function impacting cell growth and division 
EEF2	gene symbol: EEF2. Functionality: rna binding, translation elongation factor activity, gtpase activity, protein binding, gtp binding, protein kinase binding, ribosome binding, cadherin binding, hematopoietic progenitor cell differentiation, positive regulation of translation. Phenotype: involvement in skin cancer pathogenesis through alterations in protein synthesis and cell differentiation 
ANXA1	gene symbol: ANXA1. Functionality: calcium-dependent phospholipid binding, signaling receptor binding, phospholipase a2 inhibitor, actin filament colocalization, neutrophil homeostasis, immune response regulation, cell adhesion. Phenotype: involvement in skin cancer, keratinocyte differentiation, wound healing, inflammatory response, cell migration, angiogenesis, apoptotic process regulation. 
CD74	gene symbol: CD74. Functionality: mhc class ii chaperone, cytokine receptor activity, macrophage migration inhibitory factor binding, antigen presentation, protein binding. Phenotype: regulates immune response, t cell selection, b cell proliferation, cytokine production, apoptosis inhibition, skin cancer association. 
PABPC1	gene symbol: PABPC1. Functionality: rna binding; mrna binding; translation activator; mrna stabilization; mrna splicing; regulatory ncrna-mediated gene silencing; viral replication regulation; mrna decay regulation. Phenotype: involved in skin cancer through regulation of mrna stability and translation, influencing cell proliferation and survival 
LDHA	gene symbol: LDHA. Functionality: l-lactate dehydrogenase activity, protein binding, cadherin binding, glycolytic process, pyruvate metabolism, lactate metabolism. Phenotype: increased risk of skin cancer, altered energy metabolism, influence on tumor progression 
RPS3	gene symbol: RPS3. Functionality: dna repair, transcription regulation, translation, apoptosis, protein binding, ribosome structure. Phenotype: skin cancer risk, dna damage response, cell division, t cell proliferation, nf-kappab activity 
RPL35A	gene symbol: RPL35A. Functionality: trna binding, rna binding, ribosome structure, protein binding, cytoplasmic translation, rrna processing, translation, ribosomal large subunit biogenesis. Phenotype: altered ribosomal function linked to skin cancer 
DSC2	gene symbol: DSC2. Functionality: protein binding, cell adhesion, calcium ion binding, cardiac conduction regulation, cellular response to starvation, p38mapk cascade regulation. Phenotype: involved in skin cancer through disrupted cell adhesion and signaling, potentially affecting skin cell proliferation and survival. 
AQP3	gene symbol: AQP3. Functionality: water and glycerol channel activity, protein binding, urea transport, regulation of keratinocyte differentiation, immune system regulation, cellular responses to hypoxia, ischemia, retinoic acid, vitamin d, and calcium ion. Phenotype: altered water and glycerol transport, changed skin barrier function, impact on skin cancer development, affects keratinocyte behavior. 
RPS25	gene symbol: RPS25. Functionality: rna binding, ribosome structure, protein binding, translation, rrna processing, ribosomal biogenesis. Phenotype: involvement in skin cancer through disrupted translation and ribosomal functions 
IFI27	gene symbol: IFI27. Functionality: negative regulation of transcription, protein export regulation, protein binding, lamin binding, molecular adaptor activity, apoptotic process, proteasome-mediated catabolic process, viral genome replication modulation, innate immune response, interferon signaling, inflammatory response, ubiquitination, cytochrome c release. Phenotype: involvement in skin cancer due to dysregulated apoptosis, immune response alterations, transcriptional changes, and mitochondrial dysfunction. 
CALML5	gene symbol: CALML5. Functionality: protein binding, signal transduction, enzyme regulator activity, calcium ion binding, microtubule cytoskeleton organization. Phenotype: involvement in epidermis development; potential influence on skin cancer development 
YWHAZ	gene symbol: YWHAZ. Functionality: rna binding, protein binding, kinase binding, ubiquitin ligase binding, cadherin binding, phosphoserine binding, transcription regulation, protein phosphorylation, signal transduction, apoptosis regulation, immune response regulation. Phenotype: involvement in skin cancer through regulation of cell signaling, protein stability, apoptosis, and immune response, potentially impacting tumor growth and progression. 
RPL6	gene symbol: RPL6. Functionality: dna binding, rna binding, structural constituent of ribosome, protein binding, cadherin binding, cytoplasmic translation, regulation of dna-templated transcription, translation. Phenotype: altered ribosome function and protein synthesis linked to skin cancer 
TMSB4X	gene symbol: TMSB4X. Functionality: tumor necrosis factor signaling, rna binding, actin binding, protein binding, enzyme binding, protein sequestering, actin filament organization, cell migration regulation, atp synthase activity regulation. Phenotype: skin cancer risk, inflammation regulation, blood vessel endothelial cell migration, hematopoietic stem cell differentiation inhibition, cell cycle g1/s phase transition inhibition 
RPS23	gene symbol: RPS23. Functionality: rna binding, ribosome structure, protein binding, translation, translational fidelity, stress granule assembly. Phenotype: altered ribosome function, potential impact on protein synthesis, associated with skin cancer susceptibility 
RPL12	gene symbol: RPL12. Functionality: rna binding, structural constituent of ribosome, protein binding, involved in translation, cytoplasmic translation, large ribosomal subunit rrna binding. Phenotype: potential role in skin cancer through ribosomal dysregulation affecting protein synthesis and cell proliferation. 
S100A14	gene symbol: S100A14. Functionality: calcium ion binding, protein binding, chemokine receptor binding, apoptosis, lipopolysaccharide response, tlr4 signaling, bacterial defense, calcium homeostasis, regulation of chemotaxis. Phenotype: involvement in skin cancer, immune response modulation, calcium signaling, cell migration 
RPS4X	gene symbol: RPS4X. Functionality: rna binding, ribosome structural constituent, protein binding, rrna binding, translation, cell proliferation regulation, ribosomal biogenesis. Phenotype: involvement in skin cancer through deregulation of ribosomal activity and translation processes 
UBA52	gene symbol: UBA52. Functionality: ribosomal constituent, protein binding, translation, modification, ubiquitination, protein tag activity. Phenotype: skin cancer risk through altered protein synthesis and modification pathways. 
SLPI	gene symbol: SLPI. Functionality: dna binding, mrna binding, endopeptidase inhibitor activity, serine-type endopeptidase inhibitor activity, protein binding, enzyme binding, immune response, antibacterial humoral response, negative regulation of protein binding, response to lipopolysaccharide, modulation of process of another organism, negative regulation of viral genome replication, innate immune response. Phenotype: skin cancer susceptibility, immune modulation, extracellular matrix interaction. 
PKP1	gene symbol: PKP1. Functionality: dna binding, rna binding, protein binding, lamin binding, intermediate filament binding, structural constituent of skin epidermis, desmosome assembly, cell adhesion, signal transduction, gene expression regulation, keratinocyte differentiation. Phenotype: skin cancer-related; impacts cell-cell adhesion, desmosome maintenance, epidermal structure 
RPL38	gene symbol: RPL38. Functionality: rna binding, structural constituent of ribosome, protein binding, cytoplasmic translation, regulation of translation, 90s preribosome assembly, protein-rna complex assembly. Phenotype: skeletal system development, ossification, sensory perception of sound, middle ear morphogenesis, axial mesoderm development, active in postsynaptic density, located in cytosol, focal adhesion, cytoplasm, part of cytosolic large ribosomal subunit, cytosolic ribosome, eukaryotic 80s initiation complex. 
HLA-A	gene symbol: HLA-A. Functionality: enables rna binding, signaling receptor binding, protein binding, antigen binding, t cell receptor binding, cd8 receptor binding, tap binding, involved in antigen processing via mhc class i, immune response, t cell activation. Phenotype: involved in t cell mediated cytotoxicity, positive regulation of t cell cytokine production, antibacterial response, protection from nk cell cytotoxicity, detection of bacterium, tumor cell targeting, t cell proliferation. 
RPS13	gene symbol: RPS13. Functionality: rna binding, mrna binding, ribosome structural component, protein binding, mrna 5'-utr binding, translation, rna splicing regulation, ribosomal biogenesis. Phenotype: skin cancer risk due to alteration in translation and ribosome function 
LY6D	gene symbol: LY6D. Functionality: protein binding, cell adhesion, response to stilbenoid, lymphocyte differentiation. Phenotype: involved in skin cancer development, linked to cell surface activity and extracellular region localization 
RPL24	gene symbol: RPL24. Functionality: rna binding, structural constituent of ribosome, protein binding, cadherin binding, mrna binding, ribosomal subunit assembly, translation, mitosis exit, optic nerve development, axon guidance. Phenotype: skin cancer risk, impact on ribosome function, effect on cell growth and division, influence on eye development 
ATP1B3	gene symbol: ATP1B3. Functionality: enables atpase activator activity, protein binding, protein-macromolecule adaptor activity, atpase binding; involved in sodium and potassium ion homeostasis and transport, membrane repolarization, protein localization and stabilization. Phenotype: associated with skin cancer; impacts ion transport and homeostasis, influences cell signaling and membrane potential, may affect cancer cell proliferation and metastasis. 
MYL6	gene symbol: MYL6. Functionality: microfilament motor activity, cytoskeletal motor activity, calcium ion binding, protein binding, structural constituent of muscle. Phenotype: muscle contraction, skeletal muscle tissue development, muscle filament sliding, associated with skin cancer risk. 
GJB6	gene symbol: GJB6. Functionality: gap junction channel activity, protein binding, microtubule binding, actin filament binding, cell communication, transmembrane transport. Phenotype: involved in skin cancer; affects cell proliferation, electrical coupling, sensory perception, blood-brain barrier maintenance, ear morphogenesis, cell signaling. 
S100A6	gene symbol: S100A6. Functionality: calcium ion binding, protein binding, tropomyosin binding, zinc ion binding, transmembrane transporter activity, homodimerization, signal transduction, axonogenesis. Phenotype: involvement in skin cancer, positive regulation of fibroblast proliferation, extracellular matrix location, nuclear activity, cytoplasmic activity. 
HSPB1	gene symbol: HSPB1. Functionality: protein folding chaperone, kinase inhibitor, rna binding, ubiquitin binding, signal transduction, angiogenesis regulation, apoptosis regulation, protein refolding, response to stress. Phenotype: involved in skin cancer, affects angiogenesis, apoptosis, stress response, immune response, cell migration, protein folding, intracellular signaling 
RPL18	gene symbol: RPL18. Functionality: structural constituent of ribosome, protein binding, rna binding, involved in cytoplasmic translation. Phenotype: altered ribosomal function potentially linked to skin cancer development 
MT-ND2	gene symbol: MT-ND2. Functionality: nadh dehydrogenase activity, protein binding, kinase binding, glutamate receptor binding, mitochondrial electron transport, proton transmembrane transport. Phenotype: involved in skin cancer, impacts atp synthesis, reactive oxygen species metabolism, mitochondrial function, hypoxia response. 
SDC1	gene symbol: SDC1. Functionality: protein binding, cargo receptor activity, identical protein binding, receptor-mediated endocytosis, wnt signaling, exosomal secretion regulation. Phenotype: ureteric bud development, response to toxic substance, myoblast development, striated muscle and sertoli cell development, cell migration, skin cancer risk modulation. 
IVL	gene symbol: IVL. Functionality: protein binding, response to uv-b, peptide cross-linking, isopeptide cross-linking, keratinocyte differentiation, keratinization. Phenotype: skin cancer susceptibility, altered keratinocyte behavior, disrupted skin barrier function 
FTL	gene symbol: FTL. Functionality: iron ion binding, protein binding, identical protein binding, iron ion transport, intracellular iron ion homeostasis, ferric and ferrous iron binding. Phenotype: increased risk of skin cancer due to disrupted iron homeostasis and oxidative stress. 
RPS3A	gene symbol: RPS3A. Functionality: rna binding, structural constituent of ribosome, protein binding, mrna 5'-utr binding, involved in translation, translational initiation, cell differentiation, ribosomal small subunit biogenesis, negative regulation of apoptosis. Phenotype: influences skin cancer by affecting cell differentiation, apoptosis regulation, and protein synthesis in ribosomal pathways 
RPL10	gene symbol: RPL10. Functionality: rna binding, ribosomal structure, protein binding, translation regulation, transcription regulation, apoptotic regulation, brain development. Phenotype: skin cancer, translation alterations, transcription dysregulation, apoptosis anomalies, developmental issues. 
RPS15A	gene symbol: RPS15A. Functionality: rna binding, structural constituent of ribosome, protein binding, translation, regulation of cell proliferation and cell cycle, response to virus. Phenotype: increased cell proliferation, potential role in skin cancer development 
PI3	gene symbol: PI3. Functionality: endopeptidase inhibitor, structural constituent of skin epidermis, peptide cross-linking, antibacterial response, innate immunity. Phenotype: skin cancer susceptibility, epidermal structure integrity, immune response modulation 
RPL18A	gene symbol: RPL18A. Functionality: rna binding, ribosome structural constituent, protein binding, translation, cytoplasmic translation. Phenotype: altered ribosome function, potential impact on skin cancer progression 
S100A10	gene symbol: S100A10. Functionality: enables protein binding, homodimerization, transporter binding; involved in membrane raft assembly, vesicle budding, plasminogen activation, transcription regulation, neurogenesis, exocytosis; part of plasma membrane, exosome, nuclear matrix. Phenotype: associated with skin cancer progression, impacting cell adhesion, migration, and invasion processes. 
RPS7	gene symbol: RPS7. Functionality: rna binding, mrna 3'-utr and 5'-utr binding, ribosomal structure, protein and protein kinase binding, ubiquitin ligase inhibition, translation, rrna processing, gene expression regulation, protein stabilization, apoptotic signaling, neural tube closure, neural crest differentiation. Phenotype: involvement in skin cancer due to its role in translation, gene regulation, neural processes, and apoptotic signaling 
S100A7A	gene symbol: S100A7A. Functionality: protein binding, identical protein binding, transition metal ion binding, calcium-dependent binding, calcium ion binding, endothelial cell migration. Phenotype: associated with skin cancer, affects cell migration and ion binding processes 
RPL29	gene symbol: RPL29. Functionality: rna binding, ribosomal structure, heparin binding, cadherin binding, translation, embryo implantation. Phenotype: potential involvement in skin cancer through disrupted translation or ribosome function 
RPL26	gene symbol: RPL26. Functionality: rna binding, ribosome structure, protein binding, mrna 5'-utr binding, translation regulation, dna damage response, uv response, ribosome biogenesis. Phenotype: skin cancer susceptibility, uv-induced cellular response, dna damage-induced apoptosis 
RPL41	gene symbol: RPL41. Functionality: rna binding, mrna 3'-utr binding, ribosomal structure, protein binding, mrna 5'-utr binding, translation. Phenotype: role in translation, potential involvement in skin cancer pathogenesis 
RPL4	gene symbol: RPL4. Functionality: rna binding, structural constituent of ribosome, protein binding, cytoplasmic translation, translation. Phenotype: associated with skin cancer, potentially influences ribosome biogenesis and cell proliferation 
RPL7	gene symbol: RPL7. Functionality: dna binding, rna binding, mrna binding, ribosome structural constituent, protein binding, identical protein binding, cytoplasmic translation, rrna processing, translation, ribosomal large subunit biogenesis. Phenotype: potential involvement in skin cancer through disrupted ribosomal function and translation regulation 
SPARC	gene symbol: SPARC. Functionality: extracellular matrix structural constituent, calcium ion binding, protein binding, collagen binding, extracellular matrix binding. Phenotype: negative regulation of endothelial cell proliferation, positive regulation of endothelial cell migration, negative regulation of angiogenesis, regulation of cell morphogenesis, involvement in skin cancer progression 
VIM	gene symbol: VIM. Functionality: double-stranded rna binding, structural cytoskeleton component, protein binding, adaptor activity, filament binding, gene expression regulation, mrna stability regulation, intermediate filament organization. Phenotype: involvement in skin cancer due to roles in cell structure, gene expression, and response to cellular stress, affecting cell proliferation and differentiation. 
PTMA	gene symbol: PTMA. Functionality: protein binding, histone binding, transcription factor binding, involved in transcription regulation, apoptosis regulation. Phenotype: involvement in skin cancer through regulation of transcription and apoptosis. 
RPS20	gene symbol: RPS20. Functionality: rna binding, structural constituent of ribosome, protein binding, mdm2/mdm4 binding, ubiquitin ligase inhibitor, translation, p53 signal regulation. Phenotype: skin cancer susceptibility, altered protein synthesis, cell growth regulation 
MMP1	gene symbol: MMP1. Functionality: metalloendopeptidase activity, proteolysis, extracellular matrix disassembly, collagen catabolism, zinc ion binding, uv-a response. Phenotype: skin cancer association, extracellular matrix degradation, altered collagen turnover 
SH3BGRL3	gene symbol: SH3BGRL3. Functionality: protein binding, cytoskeleton organization. Phenotype: associated with skin cancer; affects cell structure and signaling 
RPL15	gene symbol: RPL15. Functionality: rna binding, structural constituent of ribosome, protein binding, cadherin binding, translation. Phenotype: increased risk of skin cancer, altered translation efficiency, abnormal cell proliferation 
MYH9	gene symbol: MYH9. Functionality: actin filament movement, motor activity, integrin binding, rna binding, cytoskeletal motor, protein binding, homodimerization, cadherin binding, atp binding, actin cytoskeleton organization, cell shape regulation, protein transport, membrane repair, platelet aggregation. Phenotype: skin cancer-associated, impacts cell migration, cytoskeleton dynamics, angiogenesis, phagocytosis, embryonic development, leukocyte migration, plasma membrane repair, monocyte differentiation, actin filament organization. 
GJA1	gene symbol: GJA1. Functionality: gap junction channel activity, signaling receptor binding, protein binding, beta-catenin binding, ion transmembrane transport, efflux transmembrane transport, tubulin binding, electrical coupling, chemical coupling, gene expression regulation, cell communication, mitotic spindle orientation, signal transduction. Phenotype: skin cancer risk, cardiac conduction, heart development, skeletal muscle regeneration, bone development, cell proliferation, neuron migration, embryonic development, blood-brain barrier maintenance, epithelial maturation, vascular morphogenesis, t cell proliferation, bone remodeling. 
ITM2B	gene symbol: ITM2B. Functionality: amyloid-beta binding, protein binding, atp binding, negative regulation of amyloid precursor protein biosynthesis, involved in nervous system development. Phenotype: associated with skin cancer, altered amyloid-beta processing, potential impact on skin cellular processes. 
PPIA	gene symbol: PPIA. Functionality: rna binding, peptidyl-prolyl isomerase activity, protein binding, integrin binding, viral interaction, protein folding, transcription regulation, kinase regulation, apoptotic process, chemotaxis, oxidative stress response, cell activation, mapk cascade regulation, secretion, nf-kappab regulation, cell adhesion. Phenotype: involvement in skin cancer through protein folding, transcription regulation, oxidative stress response, apoptosis, cell adhesion, viral interactions. 
RPL14	gene symbol: RPL14. Functionality: rna binding, structural constituent of ribosome, protein binding, cadherin binding, involved in translation, rrna processing, ribosomal large subunit biogenesis. Phenotype: altered ribosome function affecting protein synthesis, potential link to skin cancer due to disrupted cellular processes 
UBC	gene symbol: UBC. Functionality: rna binding, protein binding, ubiquitin protein ligase binding, protein tag activity, protein ubiquitination, modification-dependent protein catabolic process. Phenotype: skin cancer, altered protein degradation, abnormal cellular signaling 
RPL5	gene symbol: RPL5. Functionality: rna binding, mrna utr binding, ribosome structure, protein binding, rrna binding, ubiquitin ligase binding, translation regulation, p53 signal regulation. Phenotype: implicated in skin cancer, affects ribosomal assembly, gene expression, protein stabilization 
CD44	gene symbol: CD44. Functionality: cytokine receptor activity, protein binding, collagen binding, hyaluronic acid binding, cell adhesion, cell migration, cytokine signaling, t cell activation, dna damage response regulation, erk cascade regulation, wound healing, fibroblast growth factor response, cartilage development, monocyte aggregation. Phenotype: involved in skin cancer development, impacts cell adhesion, migration, apoptosis regulation, immune response, inflammation, and wound healing. 
AHNAK	gene symbol: AHNAK. Functionality: rna binding, protein binding, identical protein binding, s100 protein binding, cadherin binding, structural molecule activity, rna splicing regulation, voltage-gated calcium channel activity regulation, plasma membrane repair regulation. Phenotype: involvement in skin cancer through regulation of cellular structures and processes associated with membrane dynamics and signaling 
RPL21	gene symbol: RPL21. Functionality: rna binding, structural constituent of ribosome, protein binding, cytoplasmic translation, translation. Phenotype: linked to skin cancer, impacts ribosomal function, affects protein synthesis 
DSC3	gene symbol: DSC3. Functionality: gamma-catenin binding, cell adhesion, protein stabilization, calcium ion binding, active in desmosome. Phenotype: involved in skin cell adhesion, potential role in skin cancer susceptibility 
CNFN	gene symbol: CNFN. Functionality: protein binding, involved in keratinization, active in cornified envelope. Phenotype: associated with skin cancer due to disruption in keratinization process 
CD24	gene symbol: CD24. Functionality: protein binding, kinase binding, tyrosine kinase activator, cell activation, cytokine-mediated signaling, immune response regulation, wnt signaling, cell migration, epithelial cell differentiation regulation, t cell costimulation, b cell receptor transport, chemokine receptor transport, regulation of phosphorylation, cholesterol homeostasis, map kinase activity regulation, estrogen response, apoptotic signaling, cell-cell adhesion. Phenotype: skin cancer susceptibility, immune response modulation, cell proliferation, differentiation, adhesion, migration. 
CFL1	gene symbol: CFL1. Functionality: actin filament binding, cytoskeleton organization, rho signal transduction, cell morphogenesis regulation, actin filament depolymerization, spindle localization, dendritic spine morphogenesis regulation, mitotic cytokinesis, actin filament severing. Phenotype: skin cancer susceptibility, impaired cell movement, disrupted cytoskeleton dynamics, altered cell shape, enhanced viral response. 
COL17A1	gene symbol: COL17A1. Functionality: enables protein binding, contributes to extracellular matrix organization, involved in cell-matrix adhesion, hemidesmosome assembly, epidermis development. Phenotype: associated with skin integrity, basement membrane stability; mutations linked to skin cancer predisposition. 
HSP90AA1	gene symbol: HSP90AA1. Functionality: atp-dependent chaperone, protein folding, stabilization, binding (rna, mrna, atp, gtp, proteins), telomere maintenance, immune response regulation, stress response. Phenotype: skin cancer association, telomerase activity modulation, response to stress stimuli, immune and apoptotic regulation, cellular response to environmental changes. 
RPS16	gene symbol: RPS16. Functionality: rna binding, structural constituent of ribosome, protein binding, translation, rrna processing, ribosomal small subunit biogenesis, cellular response to leukemia inhibitory factor. Phenotype: alterations linked to skin cancer due to disruptions in ribosome biogenesis and protein synthesis 
PKM	gene symbol: PKM. Functionality: histone h3t11 kinase activity, magnesium ion binding, transcription coactivator, rna and mrna binding, protein tyrosine kinase, pyruvate kinase, atp binding, protein homodimerization, glycolytic process, chromatin remodeling, cell death regulation, transcription regulation, angiogenesis, translation regulation. Phenotype: involvement in skin cancer through altered glycolysis, chromatin remodeling, cell proliferation, and apoptosis regulation, localizes to nucleus, cytoplasm, mitochondrion, extracellular matrix. 
NACA	gene symbol: NACA. Functionality: dna binding, transcription coactivator, protein binding, regulates transcription by rna polymerase ii, protein transport, involved in translation, wound healing, muscle growth. Phenotype: affects skin cancer progression, influences cardiac ventricle and skeletal muscle development, regulates cell proliferation, impacts wound healing and muscle regeneration. 
RPS5	gene symbol: RPS5. Functionality: rna binding, mrna binding, rrna binding, protein binding, ribosomal structural constituent, translation, translational initiation, translational fidelity regulation, ribosomal small subunit biogenesis, ribosomal small subunit assembly. Phenotype: increased risk of skin cancer due to potential disruption in protein synthesis and cell proliferation 
ALDOA	gene symbol: ALDOA. Functionality: rna binding, actin binding, fructose-bisphosphate aldolase activity, protein binding, cytoskeletal protein binding, tubulin binding, cadherin binding, glycolytic process, atp biosynthesis. Phenotype: involved in skin cancer, affects cell shape regulation, muscle contraction, fructose metabolism, actin filament organization, cellular homeostasis, and protein homotetramerization 
H3F3B	gene symbol: H3F3B. Functionality: histone h3.3 variant involved in chromatin remodeling and gene regulation. Phenotype: alterations linked to skin cancer, affecting cell proliferation and differentiation. 
S100A16	gene symbol: S100A16. Functionality: enables rna binding, calcium ion binding, protein binding, protein homodimerization, calcium-dependent protein binding; involved in response to calcium ion. Phenotype: associated with cellular localization in extracellular space, nucleolus, cytosol, plasma membrane, and extracellular exosome; potential involvement in skin cancer. 
TAGLN2	gene symbol: TAGLN2. Functionality: protein binding, cadherin binding, actin filament binding, involved in epithelial cell differentiation, actin filament organization. Phenotype: involved in skin cancer through aberrant actin cytoskeleton organization and epithelial cell differentiation. 
HLA-C	gene symbol: HLA-C. Functionality: enables protein, peptide antigen, tap, signaling receptor binding; part of mhc class i complex; involved in antigen processing, presentation, adaptive, innate immune response; positive regulation of t cell cytotoxicity. Phenotype: associated with immune response, skin cancer susceptibility, antigen presentation, t cell regulation. 
TRIM29	gene symbol: TRIM29. Functionality: p53 binding, protein binding, zinc ion binding, cadherin binding, transcription regulation, immune response. Phenotype: skin cancer, cell adhesion, transcriptional regulation, immune modulation 
LYPD3	gene symbol: LYPD3. Functionality: laminin binding, cell-matrix adhesion, negative regulation of smooth muscle cell apoptosis. Phenotype: skin cancer susceptibility, altered cell adhesion, disrupted extracellular interactions 
FAU	gene symbol: FAU. Functionality: rna binding, ribosomal structure, protein binding, immune response, translation, ubiquitination. Phenotype: involved in skin cancer, affects immune response, protein degradation, translation processes. 
LMNA	gene symbol: LMNA. Functionality: structural molecule activity, protein binding, nuclear envelope organization, cellular senescence, gene expression regulation, telomere maintenance, protein stability regulation. Phenotype: skin cancer risk, cellular senescence, cardiac muscle development, cell migration regulation, mesenchymal cell proliferation, apoptotic signaling regulation. 
SPINK5	gene symbol: SPINK5. Functionality: serine protease inhibitor, regulates proteolysis, cell differentiation, immune response, angiogenesis, extracellular matrix, t cell differentiation. Phenotype: skin barrier defects, increased susceptibility to skin cancer, impaired immune response, epidermal differentiation abnormalities. 
SPRR2E	gene symbol: SPRR2E. Functionality: structural molecule activity, protein binding, structural constituent of skin epidermis, involved in epidermis development, peptide cross-linking, keratinization. Phenotype: associated with skin barrier integrity, impacts keratinocyte differentiation, related to skin cancer susceptibility 
RPL22	gene symbol: RPL22. Functionality: rna binding, ribosome structural constituent, protein binding, heparin binding, cytoplasmic translation, t cell differentiation, translation at presynapse. Phenotype: implicated in skin cancer due to altered protein synthesis and cell differentiation 
KRT2	gene symbol: KRT2. Functionality: structural constituent of cytoskeleton, protein binding, cytoskeletal protein binding, structural constituent of skin epidermis, involved in keratinocyte and epidermis development, peptide cross-linking, keratinization, keratinocyte activation, proliferation, migration, positive regulation of epidermis development, intermediate filament organization, active in keratin filament. Phenotype: altered keratinocyte behavior and epidermis development, potential implications in skin cancer progression. 
CST3	gene symbol: CST3. Functionality: amyloid-beta binding, protease binding, endopeptidase inhibitor, cysteine-type endopeptidase inhibitor, protein binding, peptidase inhibitor, identical protein binding, defense response, negative regulation of peptidase activity, proteolysis, collagen catabolic process, extracellular matrix disassembly, elastin catabolic process, blood vessel remodeling, tissue remodeling, supramolecular fiber organization. Phenotype: involvement in skin cancer, extracellular region activity, vesicle activity, cytoplasm activity, endoplasmic reticulum, golgi apparatus, plasma membrane, extracellular exosome activity. 
DSG3	gene symbol: DSG3. Functionality: protein binding, dimerization, desmosome assembly, actin filament organization, cell adhesion, regulation of cell migration, protein stability, adherens and tight junction assembly, ion binding. Phenotype: involved in skin integrity and cell adhesion; mutations may contribute to skin cancer risk through disrupted adhesion and migration. 
CLCA2	gene symbol: CLCA2. Functionality: metalloendopeptidase activity, chloride channel activity, metal ion binding, proteolysis, cell adhesion, ion transport, chloride transport. Phenotype: skin cancer susceptibility, altered cell adhesion, disrupted ion transport 
RPSA	gene symbol: RPSA. Functionality: virus receptor activity, dna binding, rna binding, ribosome structural constituent, laminin receptor, protein binding, ribosome binding, laminin binding, translation, cell adhesion, antiviral response. Phenotype: increased risk of skin cancer due to impaired antiviral response and cell adhesion 
DSG1	gene symbol: DSG1. Functionality: cell adhesion, calcium ion binding, protein binding, toxic substance binding. Phenotype: skin cancer development, cell-cell junction integrity, pregnancy processes 
RPS9	gene symbol: RPS9. Functionality: rna binding, ribosome structure, protein binding, translation regulation, cell proliferation, ribosomal small subunit biogenesis. Phenotype: associated with skin cancer proliferation and potential translation dysregulation. 
NDRG1	gene symbol: NDRG1. Functionality: protein binding, microtubule binding, small gtpase binding, gamma-tubulin binding, cadherin binding, negative regulation of cell proliferation, response to metal ion, dna damage response, myelin maintenance, mast cell activation, hypoxia response, signal transduction. Phenotype: involved in skin cancer, affects cell proliferation, response to dna damage, potentially impacts tumor growth and progression. 
AC090498.1	gene symbol: AC090498.1. Functionality: non-coding rna with potential regulatory roles in cellular processes. Phenotype: associated with susceptibility to skin cancer; possible influence on tumor progression. 
GRN	gene symbol: GRN. Functionality: rna binding, cytokine activity, protein binding, growth factor activity, chaperone binding, signal transduction, protein stabilization, regulation of cell migration, neuron apoptosis, angiogenesis, axon regeneration, cell proliferation, immune response, lysosome organization, lysosomal transport, protein folding. Phenotype: skin cancer-associated, impacts inflammation, affects cell migration, apoptosis, proliferation, lysosomal function. 
TXN	gene symbol: TXN. Functionality: rna binding, thioredoxin-disulfide reductase activity, protein binding, protein homodimerization, transcription regulation, response to radiation, cell redox homeostasis, signal transduction, detoxification, nitric oxide response. Phenotype: involvement in skin cancer through cell redox balance disruption, altered signal transduction, and transcription regulation affecting skin cell proliferation and survival. 
HSPA8	gene symbol: HSPA8. Functionality: protein folding, atp binding, chaperone-mediated autophagy, rna binding, protein binding, enzyme binding, signal transduction, mrna splicing, membrane organization. Phenotype: involvement in skin cancer progression, affects cell migration, protein stability, response to unfolded protein, dna transcription regulation 
TGFBI	gene symbol: TGFBI. Functionality: integrin binding, collagen binding, protein binding, extracellular matrix structural constituent, cell adhesion, angiogenesis, chondrocyte differentiation, visual perception, cell proliferation, ecm organization. Phenotype: altered cell adhesion, ecm organization, proliferation; potential involvement in skin cancer progression. 
CTSB	gene symbol: CTSB. Functionality: cysteine-type endopeptidase activity, collagen binding, protein binding, proteolysis, collagen catabolism, epithelial cell differentiation, apoptotic process regulation. Phenotype: associated with skin cancer due to involvement in extracellular matrix remodeling, cellular response regulation, and epithelial cell differentiation. 
SPRR2D	gene symbol: SPRR2D. Functionality: epidermis development, keratinization, cornified envelope, cytoplasm, cytosol. Phenotype: skin cancer risk 
HLA-DRA	gene symbol: HLA-DRA. Functionality: mhc class ii protein complex binding, antigen presentation, t cell activation, immune response regulation, peptide binding. Phenotype: involvement in immune response, t cell differentiation, potential role in skin cancer through immune modulation 
ACTN4	gene symbol: ACTN4. Functionality: rna polymerase ii transcription regulation, actin binding, integrin binding, transcription coactivator, protein binding, nuclear receptor binding, chromatin dna binding, vesicle transport, cell migration regulation, signal transduction regulation, apoptotic process regulation, cell spreading regulation. Phenotype: associated with skin cancer, impacts cell migration, actin cytoskeleton organization, stress fiber formation, cell junctions, plasma membrane dynamics, muscle cell development, extracellular interactions. 
RPS21	gene symbol: RPS21. Functionality: rna binding, structural constituent of ribosome, protein binding, cytoplasmic translation, endonucleolytic cleavage. Phenotype: abnormal ribosome biogenesis, potential predisposition to skin cancer 
EIF1	gene symbol: EIF1. Functionality: rna binding, translation initiation, protein binding, ribosomal small subunit binding, eukaryotic preinitiation complex. Phenotype: altered skin cell growth and division, potential link to skin cancer 
CTSD	gene symbol: CTSD. Functionality: aspartic-type endopeptidase, proteolysis, antigen presentation, apoptosis regulation, autophagosome assembly, insulin receptor recycling, lipoprotein catabolism. Phenotype: associated with skin cancer, impacts apoptosis, extracellular matrix interactions, influences immune response. 
ARPC2	gene symbol: ARPC2. Functionality: actin filament binding, cytoskeleton structure, protein binding, lamellipodium assembly, actin polymerization, cell motility, adhesion-dependent cell spreading, actin nucleation. Phenotype: involvement in skin cancer through altered cell motility and adhesion, impacting cancer metastasis 
CALML3	gene symbol: CALML3. Functionality: calcium ion binding, protein binding, active in cytoplasm, extracellular exosome, myelin sheath, centrosome. Phenotype: involvement in skin cancer through dysregulated calcium signaling and cellular processes. 
KLK7	gene symbol: KLK7. Functionality: metalloendopeptidase activity, peptidase activity, serine-type peptidase activity, positive regulation of antibacterial peptide production, proteolysis, epidermis development, extracellular matrix disassembly, protein maturation. Phenotype: involved in skin cancer, affects epidermal structure, contributes to skin barrier function, impacts inflammatory response 
CALM1	gene symbol: CALM1. Functionality: calcium binding, protein binding, adenylate cyclase activation, kinase binding, serine/threonine kinase activation, transmembrane transporter binding, phosphatase activation, g protein-coupled receptor signaling, jak-stat signaling, calcium-mediated signaling, organelle localization. Phenotype: skin cancer susceptibility, altered calcium signaling, modulation of cardiac muscle contraction, regulation of cytokinesis, response to interferons, presynaptic endocytosis, electrical coupling in cardiac conduction. 
GNAS	gene symbol: GNAS. Functionality: gtpase activity, g protein activity, adenylate cyclase activator, receptor binding, protein binding, signal transduction regulation, intracellular transport. Phenotype: skin cancer, hormonal regulation, bone development, cognition, thermogenesis, platelet aggregation, growth regulation. 
DYNLL1	gene symbol: DYNLL1. Functionality: enzyme inhibitor, protein binding, dynein intermediate chain binding, apoptotic process, dna damage response, negative regulation of phosphorylation, cilium assembly. Phenotype: involvement in skin cancer, affects apoptosis, dna repair, cellular transport, kinase activity regulation 
FLG	gene symbol: FLG. Functionality: calcium ion binding, protein binding, structural constituent of epidermis, transition metal ion binding, peptide cross-linking, keratinocyte differentiation, skin barrier establishment. Phenotype: skin barrier defects, increased susceptibility to skin disorders and skin cancer. 
FLNA	gene symbol: FLNA. Functionality: actin binding, receptor binding, gtpase binding, protein localization, cell migration, cytoskeleton organization, transcription regulation, kinase binding, platelet activation, cell-cell junction organization, signal transduction. Phenotype: skin cancer, cell migration, tissue remodeling, wound healing, angiogenesis, neuron migration, axon regeneration, blood coagulation, epithelial-mesenchymal transition. 
DST	gene symbol: DST. Functionality: actin binding, integrin binding, calcium ion binding, protein binding, microtubule binding, homodimerization, structural molecule activity, involved in cytoskeleton and microtubule organization, cell adhesion, integrin-mediated signaling, axonal transport, response to wounding, cell polarity, hemidesmosome assembly, cell motility. Phenotype: involved in skin cancer, affects cell adhesion, cytoskeleton organization, wound healing, cell motility, hemidesmosome function, polarity maintenance, axonal transport. 
SLC2A1	gene symbol: SLC2A1. Functionality: transmembrane transporter of glucose, fatty acids, xenobiotics; binds proteins, kinases; active in cellular response to hypoxia, insulin. Phenotype: involved in skin cancer pathogenesis; affects glucose metabolism, hypoxia response influencing tumor growth. 
PSAP	gene symbol: PSAP. Functionality: protease binding, protein binding, phospholipid binding, enzyme activator, homodimerization, scaffold protein binding, sphingolipid metabolism, lysosomal transport, autophagy regulation, ganglioside transport. Phenotype: associated with skin cancer, involves sphingolipid metabolism, lysosomal function, extracellular matrix interactions, impacts epithelial differentiation, lipid metabolism regulation. 
EIF4G2	gene symbol: EIF4G2. Functionality: rna binding, translation initiation factor activity, protein binding, regulation of translational initiation, mrna binding. Phenotype: involved in cell death, cell growth regulation, heart development, negative regulation of autophagy, skin cancer predisposition 
EEF1B2	gene symbol: EEF1B2. Functionality: translation elongation, protein binding, guanyl-nucleotide exchange, located cytoplasm, cytosol, endoplasmic reticulum. Phenotype: potential role in skin cancer through dysregulation of protein synthesis 
FGFBP1	gene symbol: FGFBP1. Functionality: protein binding, heparin binding, growth factor binding, signal transduction, regulation of cell proliferation, receptor signaling, cell migration, angiogenesis, extracellular location. Phenotype: involvement in skin cancer due to altered cell proliferation, migration, and signaling pathways. 
LGALS1	gene symbol: LGALS1. Functionality: rna binding, protein binding, receptor ligand activity, laminin binding, lactose binding, signal transduction, cell-cell adhesion. Phenotype: involved in plasma cell differentiation, apoptotic process, nf-kappab signal transduction, myoblast differentiation, viral entry regulation, inflammatory response regulation, t cell costimulation, th17 cell lineage regulation; related to skin cancer. 
ITGA6	gene symbol: ITGA6. Functionality: regulates apoptosis, cell adhesion, migration, signaling, differentiation, nail development, phosphorylation, gtpase activity, transcription, response to compounds. Phenotype: associated with skin morphogenesis, cell adhesion, leukocyte migration, potentially affecting skin cancer development. 
MYL12B	gene symbol: MYL12B. Functionality: protein binding, myosin heavy chain binding, regulation of cell shape, part of myosin ii complex. Phenotype: related to skin cancer, impacts cytoskeleton structure, influences cell motility 
TPI1	gene symbol: TPI1. Functionality: triose-phosphate isomerase activity, protein binding, methylglyoxal synthase, ubiquitin ligase binding, homodimerization. Phenotype: involvement in glycolysis, gluconeogenesis, glycerol catabolism; potential role in skin cancer due to metabolic dysregulation 
RPL10A	gene symbol: RPL10A. Functionality: rna binding, structural constituent of ribosome, protein binding, involved in cytoplasmic translation, translation, response to ethanol. Phenotype: associated with alterations in ribosomal function affecting protein synthesis, potentially influencing skin cancer development 
TMEM45A	gene symbol: TMEM45A. Functionality: protein binding, membrane localization. Phenotype: associated with skin cancer 
BTF3	gene symbol: BTF3. Functionality: rna binding, protein binding, embryonic development, protein transport, regulation of protein localization, cytosolic activity. Phenotype: skin cancer-associated, affects embryonic development, impacts protein transport 
DSTN	gene symbol: DSTN. Functionality: actin filament binding, polymerization, depolymerization, severing, fragmentation, cell motility regulation, protein binding. Phenotype: altered actin cytoskeleton dynamics, affecting cell movement, potentially influencing skin cancer progression. 
RTN4	gene symbol: RTN4. Functionality: regulation of cell migration, rna binding, protein and ubiquitin ligase binding, homodimerization, cadherin and metal ion binding, apoptotic process regulation, axon extension regulation, angiogenesis regulation, protein stabilization, synaptic transmission modulation. Phenotype: skin cancer association, impacts on cell growth, apoptosis, angiogenesis, neuron differentiation, cell adhesion, inflammatory response, hypoxia response, vasculogenesis, epithelial cell migration. 
HNRNPA2B1	gene symbol: HNRNPA2B1. Functionality: rna binding, mrna 3'-utr binding, protein binding, mirna binding, telomeric dna binding, spliceosome, mrna processing, mrna export, mirna processing, g-quadruplex dna unwinding, rna transport, telomere maintenance. Phenotype: involvement in skin cancer through dysregulation of rna processing and telomere maintenance, potentially affecting cell proliferation and genomic stability. 
LAD1	gene symbol: LAD1. Functionality: structural molecule activity, cadherin binding, located in basement membrane, actin cytoskeleton, extracellular exosome. Phenotype: involved in skin cancer, impacts cellular adhesion, structural integrity 
ATP1A1	gene symbol: ATP1A1. Functionality: sodium-potassium exchange, protein binding, atp binding, phosphatase activity, atp hydrolysis, ion binding, transmembrane transport, hormone response, cardiac function, ion homeostasis, blood pressure regulation. Phenotype: altered sodium/potassium balance, cardiac muscle function, hypertension, potential impact on skin cancer due to ion transport dysregulation. 
SERPINB3	gene symbol: SERPINB3. Functionality: protease binding, serine/cysteine endopeptidase inhibitor, virus receptor, protein binding, cell proliferation regulation, epithelial-mesenchymal transition regulation, cell migration, autocrine/paracrine signaling, catalytic activity regulation, jun kinase activity regulation, proteolysis regulation. Phenotype: involved in skin cancer progression, affecting cell migration, proliferation, and epithelial-mesenchymal transition; found in extracellular region, nucleus, cytoplasm, cytosol, plasma membrane, vesicles, azurophil granule lumen, extracellular exosome. 
PRDX1	gene symbol: PRDX1. Functionality: hydrogen peroxide catabolism, rna binding, peroxidase activity, protein binding, thioredoxin peroxidase activity, cadherin binding, nf-kappab signaling, mapk cascade regulation, redox homeostasis, oxidative stress response. Phenotype: cell proliferation, nk cell activation and cytotoxicity, erythrocyte homeostasis, leukocyte activation, fibroblast proliferation, skeletal development, superoxide removal. 
COL6A1	gene symbol: COL6A1. Functionality: collagen binding, extracellular matrix structural constituent, protein binding, cell adhesion, platelet-derived growth factor binding, response to reactive oxygen species, autophagy, mitochondrial organization, cell size regulation, energy reserve metabolism, gene expression. Phenotype: skin cancer risk, response to uv, tissue remodeling, inflammatory response, collagen fibril organization, cell morphogenesis, muscle and bone development, wound healing, response to mechanical stimulus. 
ATP5E	gene symbol: ATP5E. Functionality: encodes epsilon subunit of atp synthase; involved in atp production; mitochondrial electron transport chain. Phenotype: altered energy metabolism; associated with increased risk of skin cancer; potential oxidative stress. 
PPDPF	gene symbol: PPDPF. Functionality: cell differentiation, torc1 signaling, liver development, mitochondrial localization. Phenotype: associated with altered cell growth, potential skin cancer link 
TYMP	gene symbol: TYMP. Functionality: thymidine phosphorylase activity, oligoglucan phosphorylase activity, protein binding, growth factor activity, homodimerization, mitochondrial genome maintenance, angiogenesis, metabolic processes, chemotaxis, signal transduction, cell differentiation, nerve impulse regulation. Phenotype: involvement in skin cancer development, angiogenesis-related tumor growth, altered cell differentiation, potential impact on gastric motility. 
CD63	gene symbol: CD63. Functionality: regulates potassium ion transport, protein binding, receptor internalization, cell-matrix adhesion, protein transport, cell migration, melanosome transport, pigment maturation, vegf signaling, integrin signaling. Phenotype: influences skin cancer development, impacts cell adhesion, migration, and pigmentation, affects melanosome dynamics and signaling pathways. 
EIF5A	gene symbol: EIF5A. Functionality: rna binding, translation elongation, protein binding, u6 snrna binding, ribosome binding, transcription regulation, apoptotic signaling. Phenotype: associated with skin cancer, impacts tumor necrosis factor signaling, affects cellular virus response 
YWHAQ	gene symbol: YWHAQ. Functionality: protein binding, domain-specific binding, identical protein binding, transmembrane transporter binding, 14-3-3 protein binding, protein targeting, signal transduction, negative regulation of ion transport, transcription regulation. Phenotype: associated with skin cancer development via altered signal transduction and transcription regulation, potentially impacting cell proliferation and apoptosis 
PGK1	gene symbol: PGK1. Functionality: phosphoglycerate kinase activity, protein kinase activity, atp binding, adp binding, protein binding, reductase activity, involved in gluconeogenesis, glycolysis, angiogenesis regulation, cell differentiation, plasminogen activation, hypoxia response. Phenotype: associated with skin cancer due to roles in glycolytic process, angiogenesis, hypoxia response, metabolism regulation, epithelial cell differentiation. 
HLA-E	gene symbol: HLA-E. Functionality: signaling receptor binding, protein binding, beta-2-microglobulin binding, mhc class i protein binding, peptide antigen binding, t cell receptor binding, natural killer cell receptor binding, antigen processing and presentation, immune response regulation. Phenotype: skin cancer susceptibility, immune response modulation, natural killer cell tolerance, t cell activation and proliferation, cytokine production regulation, antibacterial response, tumor necrosis factor regulation. 
IFITM3	gene symbol: IFITM3. Functionality: immune response, virus defense, interferon response, viral entry regulation, viral transcription regulation. Phenotype: increased susceptibility to viral infections, potential impact on skin cancer progression due to immune modulation 
RPS26	gene symbol: RPS26. Functionality: rna binding, mrna binding, ribosome structural constituent, protein binding, cadherin binding, translation regulation, cytoplasmic translation. Phenotype: altered translation efficiency, potential role in skin cancer development 
IGFBP4	gene symbol: IGFBP4. Functionality: signaling receptor binding, protein binding, mapk cascade involvement, cell growth regulation, signal transduction, glucose metabolic process regulation, insulin-like growth factor binding. Phenotype: skin cancer susceptibility, altered cell proliferation, affected insulin signaling. 
OAZ1	gene symbol: OAZ1. Functionality: protein binding, ornithine decarboxylase inhibitor, polyamine biosynthesis, regulation of protein catabolism, viral translational frameshifting, protein transport. Phenotype: altered polyamine levels, impact on skin cancer progression, potential role in tumor growth and metastasis. 
NPM1	gene symbol: NPM1. Functionality: dna binding, transcription coactivator, rna binding, protein kinase inhibitor, protein binding, rrna binding, histone binding, homodimerization, ribosomal subunit binding, nf-kappab binding, unfolded protein binding, molecular adaptor, dna repair, nucleosome assembly, intracellular transport, centrosome cycle, signal transduction, apoptosis regulation. Phenotype: skin cancer association, cell proliferation regulation, centrosome duplication control, macrophage differentiation, uv response, mrna stability, cell cycle transition, cellular senescence, protein localization 
LCE3D	gene symbol: LCE3D. Functionality: protein binding, involved in keratinization, located in cytosol. Phenotype: associated with skin barrier function, potential role in skin cancer development 
FXYD3	gene symbol: FXYD3. Functionality: chloride channel activity, protein binding, atpase binding, ion transport regulation, sodium channel regulation. Phenotype: associated with skin cancer, impacts ion transport and cellular localization, affects cellular signaling. 
MT2A	gene symbol: MT2A. Functionality: protein binding, zinc ion binding, copper ion homeostasis, interleukin-3 response, erythropoietin response, growth regulation, metal ion detoxification. Phenotype: linked to skin cancer, affects cellular response to metal ions, influences metal homeostasis 
COL6A2	gene symbol: COL6A2. Functionality: protein binding, collagen binding, extracellular matrix structure, cell adhesion, uv response, glucose response, pi3k/akt signaling, neuron apoptosis. Phenotype: increased skin cancer risk, altered extracellular matrix, impaired uv response. 
POLR2L	gene symbol: POLR2L. Functionality: dna binding, rna polymerase activity, protein binding, zinc ion binding, transcription regulation. Phenotype: involvement in skin cancer through transcription alterations 
CD59	gene symbol: CD59. Functionality: regulation of complement activation, protein binding, blood coagulation, cell surface receptor signaling. Phenotype: skin cancer susceptibility, altered immune response, complement system dysregulation. 
HNRNPK	gene symbol: HNRNPK. Functionality: rna/dna binding, mrna splicing, transcription regulation, signal transduction, endocytosis regulation, apoptotic process regulation, protein domain binding, ncrna-mediated heterochromatin formation. Phenotype: skin cancer: dysregulated apoptosis, altered transcription, aberrant mrna splicing, impaired signal transduction 
RPL35	gene symbol: RPL35. Functionality: rna binding, ribosome structural constituent, cytoplasmic translation, mrna binding, ribosomal subunit maturation. Phenotype: altered ribosomal function, potential skin cancer link due to translation regulation 
TMBIM6	gene symbol: TMBIM6. Functionality: regulates calcium ion transport, protein binding, enzyme binding, ubiquitin ligase binding, endoribonuclease inhibitor, apoptosis, autophagy, rna splicing, immunoglobulin production, er stress response. Phenotype: impacts skin cancer susceptibility through modulation of apoptosis, autophagy, and er stress pathways. 
HSP90AB1	gene symbol: HSP90AB1. Functionality: protein folding, atp binding, kinase regulation, telomere maintenance, nitric oxide biosynthesis regulation, protein stabilization, chaperone activity. Phenotype: skin cancer risk, apoptosis regulation, cell cycle regulation, protein ubiquitination, cell differentiation 
